These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16972811)

  • 1. The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial.
    Gillis ME; Lumley MA; Mosley-Williams A; Leisen JC; Roehrs T
    Ann Behav Med; 2006 Oct; 32(2):135-46. PubMed ID: 16972811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. For whom does it work? Moderators of the effects of written emotional disclosure in a randomized trial among women with chronic pelvic pain.
    Norman SA; Lumley MA; Dooley JA; Diamond MP
    Psychosom Med; 2004; 66(2):174-83. PubMed ID: 15039501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does emotional disclosure about stress improve health in rheumatoid arthritis? Randomized, controlled trials of written and spoken disclosure.
    Lumley MA; Leisen JCC; Partridge TR; Meyer TM; Radcliffe AM; Macklem DJ; Naoum LA; Cohen JL; Lasichak LM; Lubetsky MR; Mosley-Williams AD; Granda JL
    Pain; 2011 Apr; 152(4):866-877. PubMed ID: 21315515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of emotional disclosure in rheumatoid arthritis: can clinician assistance enhance the effects?
    Keefe FJ; Anderson T; Lumley M; Caldwell D; Stainbrook D; Mckee D; Waters SJ; Connelly M; Affleck G; Pope MS; Weiss M; Riordan PA; Uhlin BD
    Pain; 2008 Jul; 137(1):164-172. PubMed ID: 17923329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of written emotional disclosure and coping skills training in rheumatoid arthritis: a randomized clinical trial.
    Lumley MA; Keefe FJ; Mosley-Williams A; Rice JR; McKee D; Waters SJ; Partridge RT; Carty JN; Coltri AM; Kalaj A; Cohen JL; Neely LC; Pahssen JK; Connelly MA; Bouaziz YB; Riordan PA
    J Consult Clin Psychol; 2014 Aug; 82(4):644-58. PubMed ID: 24865870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial.
    D'Souza PJ; Lumley MA; Kraft CA; Dooley JA
    Ann Behav Med; 2008 Aug; 36(1):21-32. PubMed ID: 18696172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential efficacy of written emotional disclosure for subgroups of fibromyalgia patients.
    Junghaenel DU; Schwartz JE; Broderick JE
    Br J Health Psychol; 2008 Feb; 13(Pt 1):57-60. PubMed ID: 18230233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health effects of written emotional disclosure in adolescents with asthma: a randomized, controlled trial.
    Warner LJ; Lumley MA; Casey RJ; Pierantoni W; Salazar R; Zoratti EM; Enberg R; Simon MR
    J Pediatr Psychol; 2006 Jul; 31(6):557-68. PubMed ID: 16014820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Written emotional disclosure for women with ovarian cancer and their partners: randomised controlled trial.
    Arden-Close E; Gidron Y; Bayne L; Moss-Morris R
    Psychooncology; 2013 Oct; 22(10):2262-9. PubMed ID: 23494898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Written emotional expression produces health benefits in fibromyalgia patients.
    Broderick JE; Junghaenel DU; Schwartz JE
    Psychosom Med; 2005; 67(2):326-34. PubMed ID: 15784801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the benefits of written emotional disclosure through response training.
    Konig A; Eonta A; Dyal SR; Vrana SR
    Behav Ther; 2014 May; 45(3):344-57. PubMed ID: 24680230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial.
    Hsu MC; Schubiner H; Lumley MA; Stracks JS; Clauw DJ; Williams DA
    J Gen Intern Med; 2010 Oct; 25(10):1064-70. PubMed ID: 20532650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who benefits from emotional expression? An examination of personality differences among gynaecological cancer patients participating in a randomized controlled emotional disclosure intervention trial.
    Zakowski SG; Herzer M; Barrett SD; Milligan JG; Beckman N
    Br J Psychol; 2011 Aug; 102(3):355-72. PubMed ID: 21751994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-based written emotional disclosure: the effects of advance or real-time guidance and moderation by Big 5 personality traits.
    Beyer JA; Lumley MA; Latsch DV; Oberleitner LM; Carty JN; Radcliffe AM
    Anxiety Stress Coping; 2014; 27(5):477-93. PubMed ID: 24266598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of positive and negative interpersonal events on daily fatigue in women with fibromyalgia, rheumatoid arthritis, and osteoarthritis.
    Parrish BP; Zautra AJ; Davis MC
    Health Psychol; 2008 Nov; 27(6):694-702. PubMed ID: 19025264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting to the heart of the matter: written disclosure, gender, and heart rate.
    Epstein EM; Sloan DM; Marx BP
    Psychosom Med; 2005; 67(3):413-9. PubMed ID: 15911904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of written emotional disclosure interventions in school teachers: controlling for positive expectancies and effects on health and job satisfaction.
    Ashley L; O'Connor DB; Jones F
    Psychol Health Med; 2013; 18(5):588-600. PubMed ID: 23323573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of the Fibromyalgia Assessment Status (FAS) index: a national web-based study of fibromyalgia.
    Iannuccelli C; Sarzi-Puttini P; Atzeni F; Cazzola M; di Franco M; Guzzo MP; Bazzichi L; Cassisi GA; Marsico A; Stisi S; Salaffi F
    Clin Exp Rheumatol; 2011; 29(6 Suppl 69):S49-54. PubMed ID: 22011656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.
    Wolfe F; Michaud K
    J Rheumatol; 2004 Apr; 31(4):695-700. PubMed ID: 15088293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.